Benefits
Internal UV photoprotection
A human RCT demonstrated Nutroxsun® (250 mg/day for 2 weeks) significantly increased the minimal erythemal dose (MED) — the amount of UV radiation required to cause skin redness — by 20.7% above baseline. This quantifiable internal SPF-equivalent effect is the first human clinical demonstration of oral photoprotection from a polyphenol combination supplement.
DNA damage reduction from UV exposure
Nutroxsun® significantly reduces UV-induced DNA damage markers (8-OHdG, cyclobutane pyrimidine dimers) in skin cells. These DNA lesions are the primary cause of UV-related skin aging and skin cancer initiation. Internal antioxidant protection prevents DNA damage from occurring rather than just repairing it after the fact.
Skin redness and inflammation reduction
Beyond the MED increase, Nutroxsun® significantly reduces post-UV erythema (skin redness) duration and intensity, reduces COX-2 upregulation in UV-exposed skin, and decreases prostaglandin E2 production — the inflammatory mediator driving UV-induced redness and pain.
Collagen protection and skin aging prevention
UV radiation is the primary driver of photoaging — wrinkles, pigmentation, and collagen degradation. Nutroxsun® polyphenols protect collagen from UV-induced MMP (matrix metalloprotease) activation, preserve skin elasticity, and reduce oxidative crosslinking of skin structural proteins that causes skin stiffening and wrinkling.
Complement to topical sunscreen
Nutroxsun® is not a replacement for topical SPF — it provides an additional layer of internal antioxidant protection that addresses the UV radiation that penetrates topical sunscreens, reaches deeper skin layers, or is missed by incomplete topical application. The internal + external photoprotection strategy provides more comprehensive UV defense.
Mechanism of action
Antioxidant interception of UV-generated ROS
UV radiation generates reactive oxygen species (singlet oxygen, hydroxyl radicals, superoxide) in skin tissue that damage DNA, proteins, and lipid membranes even before causing visible redness. Nutroxsun® polyphenols accumulate in skin tissue and intercept these ROS at the moment of formation, reducing oxidative DNA damage before lesions form.
COX-2 and inflammatory eicosanoid suppression
Rosmarinic acid and naringenin inhibit UV-induced COX-2 upregulation in keratinocytes, reducing prostaglandin E2 and other pro-inflammatory eicosanoids that drive erythema (redness), pain, and the inflammatory cascade that promotes photocarcinogenesis. This anti-inflammatory mechanism directly reduces the MED-based redness endpoint measured in clinical trials.
Nrf2 activation and endogenous antioxidant enzyme induction
Carnosic acid (rosemary) and naringenin (grapefruit) activate Nrf2, inducing expression of glutathione peroxidase, superoxide dismutase, and catalase specifically in skin tissue. This endogenous antioxidant upregulation provides sustained protection that continues beyond the direct scavenging lifespan of the ingested polyphenols themselves.
Clinical trials
Randomized, double-blind, placebo-controlled trial of Nutroxsun® (250 mg/day rosemary + grapefruit polyphenol blend) vs placebo in 30 healthy adults for 2 weeks. Outcomes: minimal erythemal dose (MED), skin parameters. (Pérez-Sánchez et al. 2014, J Photochem Photobiol B)
30 healthy adults. 2-week intervention.
Nutroxsun® increased MED by 20.7% above baseline vs no change in placebo. Critical caveat: the ~20% MED elevation is meaningful but should not be interpreted as 'oral sunscreen' — topical sunscreen remains the foundation of UV protection. Industry-funded (Monteloeder).
Extended assessment of Nutroxsun® effects on skin quality markers, collagen integrity, and photoprotective capacity over 12 weeks. Note: full peer-reviewed publication may be limited; primary documentation through SuanNutra/Monteloeder.
Long-term: 90 participants in 2-month double-blind, randomized, parallel study; 100 or 250 mg Nutroxsun™ vs placebo; primary endpoints minimal erythema dose (MED), wrinkle depth, skin elasticity. Acute crossover (2025): 20 participants, 100 or 250 mg vs placebo, UV exposure with 24-hour redness/recovery assessment.
Long-term: Nutroxsun™ significantly increased MED (cumulative photoprotection), reduced UVB/UVA-induced lipid peroxidation, and improved wrinkle depth and skin elasticity. Acute (2025): 250 mg significantly reduced UV-induced erythema and accelerated 24-hour skin recovery vs placebo. In vitro: rosemary + grapefruit polyphenols inhibit ROS, IL release, and MMP-1/3, preserving collagen and elastin. Two-mechanism evidence base — acute response and chronic photoprotection.